SEC Form 4 · accession 0001019687-15-002238
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McLaughlin
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Rights to Buy)F1 | $0.90 | Jun 1, 2015 | A | 10,610 | A | Jun 1, 2015 | Jun 1, 2025 | Common Stock | 10,610 | 130,882 | D |
Explanation of responses
- F1The options were granted by the Issuer pursuant to the Non-Employee Director Compensation Plan.